Puma Biotechnology, Inc.
Cash Flow Statement
| Line Item | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | Dec 2018 | Sep 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $3.4M | $-16.9M | $-11.2M | $-16.9M | $-37.4M | $-10.1M | $-30.7M | $-14.2M |
| Depreciation & Amortization | $2.2M | $1.9M | $1.9M | $1.9M | $2.1M | $2.1M | $2.1M | $2.1M |
| Depreciation | $300.0K | $200.0K | — | $200.0K | — | $200.0K | — | — |
| Amortization | $1.3M | $1.0M | $900.0K | $1.0M | $1.0M | $1.0M | $900.0K | $1.0M |
| Stock-Based Compensation | $10.6M | $8.9M | $11.5M | $12.2M | $15.4M | $18.1M | $18.6M | $20.8M |
| Net Cash from Operating Activities | $16.2M | $-11.5M | $1.6M | $-7.3M | $44.2M | $-16.1M | $7.0M | $-7.3M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | $-111.0K | $305.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-9.2M | $34.4M | $-432.0K | $39.0M | $11.2M | $-44.6M | $2.6M | $-21.4M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $-1.0K | $76.0K | $-68.2M | $1.1M | $30.5M | $1.0M |
| Net Change in Cash | $7.0M | $22.8M | $1.1M | $31.7M | $-12.8M | $-59.6M | $40.1M | $-27.6M |
| Free Cash Flow | — | — | — | — | — | — | $7.2M | $-7.6M |